TY - JOUR A1 - Lobet, Sébastien A1 - Timmer, Merel A1 - Königs, Christoph A1 - Stephensen, David A1 - McLaughlin, Paul A1 - Duport, Gaetan A1 - Hermans, Cédric A1 - Mancuso, Maria Elisa T1 - The role of physiotherapy in the new treatment landscape for haemophilia T2 - Journal of Clinical Medicine N2 - The physiotherapist plays an essential role for people with haemophilia, an inherited bleeding disease responsible for musculoskeletal complications. Yet, with the advent of new and advanced therapies, the medical landscape is changing, and physiotherapy must adapt alongside. This paper considers whether there will still be a need for physiotherapy in the era of advanced therapies, and discusses ways in which services should evolve to complement emerging treatment paradigms for haemostasis in people with haemophilia. Ultimately, physiotherapy will remain an important element of care, even for people with little joint damage and low risks in the era of the new mild phenotype. However, competencies will need to evolve, and physiotherapists in both primary care and specialist treatment centres should work with haematology colleagues to develop more sensitive tools for detecting early joint changes. Physiotherapists will also play a crucial role in counselling and physically coaching, monitoring the musculoskeletal status of people with haemophilia who have transitioned to new treatments. KW - physiotherapy KW - haemophilia KW - EHL concentrates KW - emicizumab KW - trough levels KW - gene therapy Y1 - 2021 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/62166 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-621668 SN - 2077-0383 N1 - This research was funded by an unrestricted educational grant from BioMarin, which was handled by ELM Medical. BioMarin had no involvement in the planning, nor in the writing of the manuscript, which was developed by the authors alone in collaboration with ELM and Synthesis Editorial Ltd. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. VL - 10 IS - 13, art. 2822 SP - 1 EP - 11 PB - MDPI CY - Basel ER -